SCHEDULE 13G/A: FMR LLC and Abigail P. Johnson Disclose 14.5% Stake in Outset Medical Inc.
Beneficial Ownership Report
FMR LLC and its affiliates, along with Abigail P. Johnson, have disclosed a combined beneficial ownership of 14.5% in Outset Medical Inc., as detailed in their latest Schedule 13G filing.
Summary
- FMR LLC and Abigail P. Johnson, through various affiliated entities, collectively beneficially own 2,596,861 shares of Outset Medical Inc.'s common stock.
- This aggregate ownership represents 14.5% of the total outstanding common stock of Outset Medical Inc. as of March 31, 2025.
- FMR LLC holds sole voting power over 2,595,865 shares and sole dispositive power over 2,596,861 shares.
- Abigail P. Johnson, as a control person of FMR LLC, is deemed to beneficially own the same aggregate amount of shares.
- One or more other persons, specifically Select Health Care Portfolio, are known to have the right to receive dividends or proceeds from 1,332,900 shares, representing 7.4% of the total outstanding common stock as of March 31, 2025.
- The filing is an Amendment No. 7 to a previously filed Schedule 13G, indicating an update to their ownership position.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain subjective language or performance metrics that would indicate a strong positive or negative sentiment. The sentiment is neutral, reflecting a standard regulatory filing.
Positives
- The disclosure of a significant 14.5% beneficial ownership stake by a major institutional investor like FMR LLC and its affiliates can be interpreted by the market as a vote of confidence in Outset Medical Inc.
Future Outlook
NA
Industry Context
This filing is a routine disclosure of a significant ownership stake by a large asset management firm in a publicly traded company within the medical technology sector. It does not provide specific insights into Outset Medical Inc.'s operational performance or broader industry trends, but rather reflects an investment position.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Ownership Structure and Control | Members of the Johnson family, including Abigail P. Johnson, are the predominant owners (49% voting power) of Series B voting common shares of FMR LLC. They have a shareholders' voting agreement to vote Series B shares in accordance with the majority, forming a controlling group with respect to FMR LLC under the Investment Company Act of 1940. | NA | This structure centralizes control over FMR LLC's voting decisions, including those related to its investment holdings. |
Stakeholder Impact
- Shareholders of Outset Medical Inc. may view the significant and continued stake by FMR LLC as a positive signal, potentially indicating institutional confidence in the company's long-term prospects.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of event which requires the filing of this statement, reflecting the beneficial ownership percentage. |
| 04/04/2025 | Date the Schedule 13G Amendment No. 7 was signed and filed. |
Keywords
Outset Medical Inc., FMR LLC, Abigail P. Johnson, Beneficial Ownership, Schedule 13G, Common Stock, Institutional Investor, Ownership Disclosure, Medical Devices
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.